Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide- enhanced radioresistance
暂无分享,去创建一个
R. Schreiber | T. MacVittie | R. Neta | R. Chizzonite | J. Oppenheim | G. D. Ledney | G. Ledney | J. J. Oppenheim | R. Neta | R. D. Schreiber | R. Chizzonite | T J MacVittie
[1] C. Dubois,et al. Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action , 1990, The Journal of experimental medicine.
[2] T. Fahey,et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. N. Vogel,et al. In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6. , 1990, Blood.
[4] P. Quesenberry,et al. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. , 1990, Blood.
[5] G. Woloschak,et al. Modulation of gene expression in Syrian hamster embryo cells following ionizing radiation. , 1990, Cancer research.
[6] D. Hallahan,et al. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Kaffka,et al. Two high-affinity interleukin 1 receptors represent separate gene products. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Turner,et al. Modulation of cytokine production by transforming growth factor-beta. , 1989, Journal of immunology.
[9] R. Schreiber,et al. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. , 1989, Journal of immunology.
[10] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.
[11] R. Neta,et al. Cytokines in therapy of radiation injury. , 1988, Blood.
[12] F. Ruscetti,et al. Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines , 1988, The Journal of experimental medicine.
[13] P. Segarini,et al. Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. , 1988, Cellular immunology.
[14] A. Roberts,et al. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. , 1988, Journal of immunology.
[15] R. Neta,et al. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. , 1988, Journal of immunology.
[16] R. Nordan,et al. Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. , 1988, Lymphokine research.
[17] M. Sporn,et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Shepard,et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta , 1987, The Journal of experimental medicine.
[19] J. Vilček,et al. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. , 1987, Journal of immunology.
[20] J. Vilček,et al. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[21] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[22] B. Beutler,et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.
[23] J. Larrick,et al. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.
[24] R. Neta,et al. Interleukin 1 is a radioprotector. , 1986, Journal of immunology.
[25] B. Beutler,et al. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.
[26] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Metcalf. Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels. , 1971, Immunology.
[28] D. Bekkum. BONE MARROW TRANSPLANTATION AND PARTIAL BODY SHIELDING FOR ESTIMATING CELL SURVIVAL AND REPOPULATION. , 1969 .
[29] F. L. Jennings. Mammalian Radiation Lethality: A Disturbance in Cellular Kinetics , 1966 .
[30] J. Youngner,et al. Interferon Appearance Stimulated by Endotoxin, Bacteria, or Viruses in Mice Pre-Treated with Escherichia coli Endotoxin or Infected with Mycobacterium tuberculosis , 1965, Nature.
[31] E. J. Ainsworth,et al. Effect of Microbial Antigens on Irradiation Mortality in Mice.∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[32] W. W. Smith,et al. Increased survival in irradiated animals treated with bacterial endotoxins. , 1957, The American journal of physiology.